{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:24:33Z","timestamp":1790274273505,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinre.2026.102875","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:42:13Z","timestamp":1782776533000},"page":"102875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of intermittent fasting on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Qinhan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2026.102875_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol & Hepatol"},{"issue":"22","key":"10.1016\/j.clinre.2026.102875_bib0002","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA, J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu Rev Pathol: Mech Dis"},{"issue":"21","key":"10.1016\/j.clinre.2026.102875_bib0004","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0005","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0006","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ijms21010360","article-title":"Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL\/6 mice model via AMPK\/Sirt1\/SREBP-1c\/PPAR\u03b3 pathway","volume":"21","author":"Chyau","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.clinre.2026.102875_bib0007","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0009","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102875_bib0011","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","article-title":"Semaglutide therapy for metabolic dysfunction\u2013associated steatohepatitis: November 2025 updates to AASLD Practice Guidance","volume":"83","author":"Bansal","year":"2026","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2026.102875_bib0012","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2026.102875_bib0013","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/nutrit\/nuad026","article-title":"Effects and possible mechanisms of intermittent fasting on health and disease: A narrative review","volume":"81","author":"Li","year":"2023","journal-title":"Nutr Rev"},{"key":"10.1016\/j.clinre.2026.102875_bib0014","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-nutr-052020-041327","article-title":"Cardiometabolic benefits of intermittent fasting","volume":"41","author":"Varady","year":"2021","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","article-title":"Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase","volume":"11","author":"Byun","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0016","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/nu14030433","article-title":"Traditional and medical applications of fasting","volume":"14","author":"Visioli","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0017","article-title":"The Health-Promoting Effects and the Mechanism of Intermittent Fasting","volume":"2023","author":"Liu","year":"2023","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0018","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12876-019-1132-8","article-title":"Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial","volume":"19","author":"Cai","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5114\/ceh.2022.115056","article-title":"Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients","volume":"8","author":"Badran","year":"2022","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.clinre.2026.102875_bib0020","first-page":"105","article-title":"Effects of time-restricted feeding (16\/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: a randomized controlled trial","author":"Kord-Varkaneh","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.clinre.2026.102875_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47763-8","article-title":"A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease","volume":"9","author":"Johari","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2026.102875_bib0022","first-page":"435","volume":"41","author":"Hashem","year":"2021"},{"issue":"7","key":"10.1016\/j.clinre.2026.102875_bib0023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/adc.2010.199760","article-title":"Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement","volume":"96","author":"Koot","year":"2011","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.clinre.2026.102875_bib0024","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clinre.2026.102875_bib0025","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","article-title":"Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials","volume":"73","author":"Davison","year":"2020","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.clinre.2026.102875_bib0026","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000081","article-title":"Detection of liver steatosis with a novel ultrasound-based technique: a pilot study using MRI-derived proton density fat fraction as the gold standard","volume":"10","author":"Ferraioli","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102875_bib0027","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10620-016-4037-1","article-title":"Quantitative imaging biomarkers of NAFLD","volume":"61","author":"Kinner","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0028","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1148\/rg.341135130","article-title":"Fat-suppression techniques for 3-T MR imaging of the musculoskeletal system","volume":"34","author":"Del Grande","year":"2014","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.gastro.2017.06.005","article-title":"Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis","volume":"153","author":"Middleton","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2026.102875_bib0031","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.clinre.2026.102875_bib0032","doi-asserted-by":"crossref","first-page":"W-65-W-94","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2026.102875_bib0033","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. 2008.","DOI":"10.1002\/9780470712184"},{"issue":"7414","key":"10.1016\/j.clinre.2026.102875_bib0034","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100256","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet \u2013 a randomised controlled trial","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEP Reports"},{"key":"10.1016\/j.clinre.2026.102875_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.948655","article-title":"Effects of the 5: 2 intermittent fasting diet on non-alcoholic fatty liver disease: a randomized controlled trial","volume":"9","author":"Kord Varkaneh","year":"2022","journal-title":"Front Nutr"},{"issue":"6","key":"10.1016\/j.clinre.2026.102875_bib0037","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/nu15061398","article-title":"Alternate-Day Fasting Combined with Exercise: Effect on Sleep in Adults with Obesity and NAFLD","volume":"15","author":"Ezpeleta","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clinre.2026.102875_bib0038","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0168-8278(23)00518-4","article-title":"Calorie restriction by time restricted intermittent fasting is better than standard calorie restriction in improving the metabolic profile and hepatic fibrosis in patients with non-alcoholic fatty liver disease","volume":"78","author":"Aggarwal","year":"2023","journal-title":"J Hepatol"},{"issue":"23","key":"10.1016\/j.clinre.2026.102875_bib0039","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.3390\/nu15234870","article-title":"Time-restricted fasting improves liver steatosis in non-alcoholic fatty liver disease\u2014a single blinded crossover trial","volume":"15","author":"Feehan","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.3513","article-title":"Effects of time-restricted eating on nonalcoholic fatty liver disease: the TREATY-FLD randomized clinical trial","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0041","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/oby.23965","article-title":"Effects of time-restricted eating on intrahepatic fat and metabolic health among patients with nonalcoholic fatty liver disease","volume":"32","author":"Deng","year":"2024","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"5","key":"10.1016\/j.clinre.2026.102875_bib0042","article-title":"Effects of intermittent fasting on liver steatosis and fibrosis, serum fgf-21 and autophagy markers in metabolic dysfunction-associated fatty liver disease: a randomized controlled trial","volume":"15","author":"Ozlu Karahan","year":"2025","journal-title":"Life (Basel)"},{"issue":"6","key":"10.1016\/j.clinre.2026.102875_bib0043","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/dmrr.2751","article-title":"The perilipin 2 (PLIN2) gene Ser251Pro missense mutation is associated with reduced insulin secretion and increased insulin sensitivity in Italian obese subjects","volume":"32","author":"Sentinelli","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinre.2026.102875_bib0044","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2018.05.042","article-title":"Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver","volume":"275","author":"Sung","year":"2018","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0045","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000316","article-title":"Moderate-intensity aerobic vs resistance exercise and dietary modification in patients with nonalcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Charatcharoenwitthaya","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3350\/cmh.2020.0239","article-title":"Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"27","author":"Wijarnpreecha","year":"2021","journal-title":"Clin Mol Hepatol"},{"issue":"21","key":"10.1016\/j.clinre.2026.102875_bib0047","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clinre.2026.102875_bib0048","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/ncpendmet0809","article-title":"Differentiating between body fat and lean mass\u2014how should we measure obesity?","volume":"4","author":"Romero-Corral","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0049","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jacl.2020.12.010","article-title":"Interrogation of selected genes influencing serum LDL-cholesterol levels in patients with well characterized NAFLD","volume":"15","author":"Vilar-Gomez","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.clinre.2026.102875_bib0050","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.clinre.2026.102875_bib0051","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clnu.2024.01.005","article-title":"Various types of fasting diet and possible benefits in nonalcoholic fatty liver: mechanism of actions and literature update","volume":"43","author":"Mirrazavi","year":"2024","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/srep39328","article-title":"Multiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicide","volume":"7","author":"Mesnage","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.clinre.2026.102875_bib0053","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/liv.15601","article-title":"Zebrafish facilitate non-alcoholic fatty liver disease research: Tools, models and applications","volume":"43","author":"Chang","year":"2023","journal-title":"Liver International"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0054","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","article-title":"Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions","volume":"68","author":"Loomba","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2026.102875_bib0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12072-016-9772-z","article-title":"Non-invasive diagnosis of hepatic steatosis","volume":"11","author":"Stern","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinre.2026.102875_bib0056","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","article-title":"Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"29","author":"Gu","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0057","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1522-2594(200003)43:3<325::AID-MRM1>3.0.CO;2-8","article-title":"Motion correction and lipid suppression for 1H magnetic resonance spectroscopy","volume":"43","author":"Star-Lack","year":"2000","journal-title":"Magn Reson Med: An Off J Int Soc Magn Reson Med"},{"issue":"4","key":"10.1016\/j.clinre.2026.102875_bib0058","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10396-021-01106-1","article-title":"Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)","volume":"48","author":"Ferraioli","year":"2021","journal-title":"J Med Ultrason"},{"issue":"3","key":"10.1016\/j.clinre.2026.102875_bib0059","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","article-title":"Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis","volume":"6","author":"Petroff","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102875_bib0060","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2026.102875_bib0061","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0062","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5009\/gnl15155","article-title":"Relationship between controlled attenuation parameter and hepatic steatosis as assessed by ultrasound in alcoholic or nonalcoholic fatty liver disease","volume":"10","author":"Ahn","year":"2016","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.clinre.2026.102875_bib0063","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2026.102875_bib0064","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","article-title":"Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD","volume":"18","author":"Tamaki","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"153","key":"10.1016\/j.clinre.2026.102875_bib0065","article-title":"Assessment of the metabolic effects of isocaloric 2: 1 intermittent fasting in mice","author":"Kim","year":"2019","journal-title":"JoVE (Journal of Visualized Experiments)"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0066","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S000711451800137X","article-title":"Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial","volume":"120","author":"Katsagoni","year":"2018","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clinre.2026.102875_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.838091","article-title":"Efficacy and mechanism of intermittent fasting in metabolic associated fatty liver disease based on ultraperformance liquid chromatography-tandem mass spectrometry","volume":"9","author":"Deng","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinre.2026.102875_bib0068","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.926789","article-title":"Intermittent fasting improves lipid metabolism through changes in gut microbiota in diet-induced obese mice","volume":"26","author":"Deng","year":"2020","journal-title":"Med Sci Monit: Int Med J Experim Clin Res"},{"issue":"4","key":"10.1016\/j.clinre.2026.102875_bib0069","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3748\/wjg.v25.i4.509","article-title":"Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease","volume":"25","author":"Biolato","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"11-12","key":"10.1016\/j.clinre.2026.102875_bib0070","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.nut.2009.09.001","article-title":"Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease","volume":"26","author":"Elias","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.clinre.2026.102875_bib0071","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/cdn\/nzab055_031","article-title":"Effects of a low carbohydrate diet on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease (NAFLD)","volume":"5","author":"Khorunzha","year":"2021","journal-title":"Curr Dev Nutr"},{"issue":"26","key":"10.1016\/j.clinre.2026.102875_bib0072","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"De Cabo","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102875_bib0073","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-nutr-052020-041327","article-title":"Cardiometabolic benefits of intermittent fasting","volume":"41","author":"Varady","year":"2021","journal-title":"Annu Rev Nutr"},{"issue":"11","key":"10.1016\/j.clinre.2026.102875_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258853","article-title":"A randomised controlled trial of the 5: 2 diet","volume":"16","author":"Hajek","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clinre.2026.102875_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114865","article-title":"Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock","volume":"43","author":"Sun","year":"2024","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.clinre.2026.102875_bib0076","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4093\/dmj.2025.0644","article-title":"Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications","volume":"49","author":"Truong","year":"2025","journal-title":"Diabetes Metab J"},{"issue":"9","key":"10.1016\/j.clinre.2026.102875_bib0077","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/jgh.17037","article-title":"Mechanism of semaglutide in MASLD treatment: where is the master key?","volume":"40","author":"Ezhilarasan","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.clinre.2026.102875_bib0078","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.3390\/ijms26199643","article-title":"Dietary and pharmacological modulation of aging-related metabolic pathways: molecular insights, clinical evidence, and a translational model","volume":"26","author":"Murillo-Cancho","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clinre.2026.102875_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101780","article-title":"Ethnic differences in metabolic and histologic features among White, Hispanic, Black and Asian patients with metabolic-associated Steatotic liver disease: A network meta-analysis","volume":"30","author":"Lin","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinre.2026.102875_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1251122","article-title":"A single 36-h water-only fast vastly remodels the plasma lipidome","volume":"10","author":"Hong","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.clinre.2026.102875_bib0081","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clnesp.2023.11.009","article-title":"Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials","volume":"59","author":"Saleh","year":"2024","journal-title":"Clin Nutr ESPEN"},{"issue":"8","key":"10.1016\/j.clinre.2026.102875_bib0082","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000212","article-title":"Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"7","author":"Lange","year":"2023","journal-title":"Hepatol Commun"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012600121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012600121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:46:04Z","timestamp":1788223564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221074012600121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S221074012600121X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102875","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of intermittent fasting on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102875"}}